Peripheral Arterial Disease (PAD)

Cordis Corp. announced the launch of the new Elitecross support catheter in the United States and Outback Elite re-entry catheter in the United States, Europe and Japan. This expands the Cordis Crossing Portfolio for treatment of chronic total occ...

The U.S. Food and Drug Administration (FDA) approved Abbott’s Supera Peripheral Stent System to treat people with blocked blood vessels in the upper leg caused by peripheral artery disease (PAD).

The U.S. Food and Drug Administration (FDA) cleared Cardiovascular Systems Inc.’s Diamondback 360 60 cm Peripheral Orbital Atherectomy Systems (OAS) for the treatment of peripheral arterial disease (PAD).

bard, DEB, drug eluting balloon

The first clinical trial in the United States to study the use of drug-coated ...

Lutonix DCB, CMS, reimbursement, pass-through payment, outpatient use
C.R. Bard Inc. announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has improved the pass-through payment for the Lutonix drug-coated...
Biotronik, Pulsar-18, Michael Lichtenberg, study
Biotronik announced the publication of promising clinical results regarding its Pulsar-18 stent platform. Adding to the similarly encouraging data collected in...
Cordis Corp., Cordis Crossing Portfolio, Elitecross, Outback Elite, CTO
Cordis Corp. announced the launch of the new Elitecross support catheter in the United States and Outback Elite re-entry catheter in the United States, Europe...
Shockwave Medical, Lithoplasty, $40 million, funding, Sofinnova, Venrock
Shockwave Medical announced $40 million in funding, co-led by returning investor Sofinnova Partners and new investor Venrock. Also participating were RA...
Cordis Corp., Cordis Crossing Portfolio, Elitecross, Outback Elite, CTO
Cordis Corp. announced the launch of The new Elitecross support catheter and Outback Elite re-entry catheter expand Cordis Corp.'s Cordis
Medtronic’s In.Pact Admiral drug-coated balloon (DCB) is for the interventional treatment of peripheral artery disease (PAD) for the...
The RadAR vascular compression device from Advanced Vascular Dynamics is specified for post-procedure hemostasis of tibiopedal access...

Articles

Shockwave Medical, Lithoplasty, $40 million, funding, Sofinnova, Venrock
Shockwave Medical announced $40 million in funding, co-led by returning investor Sofinnova Partners and new investor Venrock. Also participating were RA...
Cardinal Health announced plans to acquire Johnson & Johnson’s Cordis business, a leading global manufacturer of cardiology and endovascular devices, for $...
Hielscher, Columbia, PAD, OCT, diabetes, optical tomographic imaging, peripheral
Approximately 8 to 12 million people in the United States alone are suffering from peripheral arterial disease (PAD), a common vascular problem that is also...
Medtronic, In.Pact Admiral DEB, drug coated balloon, drug eluting balloon
Drug-eluting balloons (DEBs) have been one of the long-awaited new transcatheter technologies to help reduce high restenosis rates in peripheral artery disease...

Video Center

Here are a few observations on cardiovascular ultrasound advances I made while attending the 2015...
5 days 22 hours ago
The latest advances in cardiovascular echocardiography will be presented at the 2015 American...
3 weeks 1 day ago
There were several technology takeaway messages for the future of electrophysiology (EP) at the...
6 weeks 1 day ago
Centricity, webinar, ZFV, ZFP, viewer, remote viewing system, enterprise
Healthcare organizations are demanding more capabilities for image viewers accessed by clinicians. Zero footprint (ZFP) viewers provide imaging tools from...
The webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" educates participants about the state of the art clinical and emerging translational...
This webinar discusses why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient and...

Comparison Charts

Sorry there is no data available